Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivale...

Shares of Merck and Moderna jumped early Tuesday after the drugmakers said a potential skin cancer vaccine they are deve...

Merck turned in a better-than-expected third quarter and raised its 2022 forecast as the drugmaker’s top seller brought...

Better-than-expected sales of its COVID-19 treatment and the cancer blockbuster Keytruda helped push Merck past analyst...

The blockbuster cancer treatment Keytruda pushed Merck past fourth-quarter expectations, and the drugmaker’s COVID-19 tr...

Japan has approved the COVID-19 pill developed by U.S. pharmaceutical company Merck & Co. for use beginning next week

U.S. regulators have authorized a second pill against COVID-19, an antiviral drug from Merck that may help blunt the wav...

The European Medicines Agency says it has received a request from Merck to authorize its coronavirus antiviral, the firs...

Britain has granted a conditional authorization to Merck’s coronavirus pill.

The blockbuster cancer treatment Keytruda and the vaccine Gardasil pushed Merck well past Wall Street’s third-quarter ex...